Johnson & Johnson (JNJ)

$146.14 0.68 (0.46%)

16:10 EDT JNJ Stock Quote Delayed 30 Minutes

How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?

By Alex Sirois, InvestorPlace Contributor Apr 26, 2024

Curious to know how much these dividend aristocrats could grow in the next year? Here's the answer for several well-known shares.

3 Long-Term Stocks to Buy on the Dip: April 2024

7 Blue-Chip Stocks to Buy on the Dip: April 2024

Spring Awakening: 3 Dow Stocks Emerging from Hibernation

Volume:

Previous Close -

Market Cap 384.16B

PE Ratio -

EPS -

Volume (Avg. Vol.) 6.17M

Day's Range $145.95 - $147.18

52-Week Range $143.13 - $175.97

Dividend & Yield $4.76 (3.26%)

JNJ Stock Predictions, Articles, and Johnson & Johnson News

From InvestorPlace
From the Web

The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 24, 2024

Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.

Surprise! These 3 Dividend Giants Are at 52-Week Lows. Buy Them Before They Soar

By Rich Duprey, InvestorPlace Contributor Apr 24, 2024

Buying dividend giants at 52-week lows is a smart investment strategy to generate the greatest returns when they rebound.

Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red

By Joel Baglole, InvestorPlace Contributor Apr 23, 2024

These stocks are underwater right now and likely to remain so as the companies behind them manage serious problems.

3 Dividend Stocks to Buy Now for Lifelong Income

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 22, 2024

Here are three dividend stocks to buy now offering stability, growth, and lifelong income in the pharmaceutical and tobacco industries.

5 Crash-Proof Stocks to Buy Immediately

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Apr 22, 2024

We may not be headed to a full-blown crisis, but savvy investors should protect their portfolios now with these crash-proof stocks.

Investing for the Long-Term: 3 Stocks With Proven Track Records

By Philippa Main, InvestorPlace Contributor Apr 20, 2024

As uncertainty in the global economy and geopolitical climate abounds, investors should focus on stocks with proven track records.

Recession-Proof Riches: 3 Stocks That Thrive in Any Economy

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 18, 2024

Discover recession-proof stocks that thrive amid economic uncertainty, offering stability and consistent growth.

Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.

By Joel Baglole, InvestorPlace Contributor Apr 18, 2024

Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.

Put $10,000 in These 3 Dividend Stocks by 2025

By Vandita Jadeja Apr 17, 2024

In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income.

JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings Apr 16, 2024

JNJ stock results show that Johnson & Johnson beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash

By Rich Duprey, InvestorPlace Contributor Apr 14, 2024

You never know when a downturn will hit so it pays to prepare for the worst by buying these stocks before a market crash.

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor Apr 11, 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

All-Time High Flyers: 7 Stocks to Buy as the Market Peaks

By Joel Baglole, InvestorPlace Contributor Apr 11, 2024

These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.

Why Is Rallybio (RLYB) Stock Up 93% Today?

By William White, InvestorPlace Writer Apr 11, 2024

Rallybio stock is rocketing higher on Thursday with heavy trading of RLYB shares after announcing a collaboration with Johnson & Johnson.

Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024

By Chris Markoch, InvestorPlace Contributor Apr 10, 2024

These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

By Josh Enomoto, InvestorPlace Contributor Apr 10, 2024

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access…

If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names

By Michael Que, InvestorPlace Contributor Apr 10, 2024

The economy is performing pretty well, investing in these top dividend stocks to buy will guarantee good profits.

SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson

By Dana Blankenhorn, InvestorPlace Contributor Apr 5, 2024

JNJ is building a suite of heart disease treatment devices and hopes integration can help it avoid a patent cliff.

3 Value Stocks to Buy on the Dip: March 2024

By Josh Enomoto, InvestorPlace Contributor Mar 28, 2024

If you’ve been following the headlines, you’ll be well aware of the value behind value stocks to buy. Basically, the smart money sees some risks…

7 Dow Stocks to Buy on the Dip: March 2024

By Ian Bezek, InvestorPlace Contributor Mar 27, 2024

Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back.

Johnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies’ baby powders for giving her a fatal cancer in what was the first verdict against the J&J spinoff in a decade-long litigation over the product.

MarketBeat Week in Review – 4/15 - 4/19

From MarketBeat Apr 20, 2024

The markets continued to move lower ahead of a big earnings week as analysts adjust valuations on the outlook for interest rates and geopolitical concerns

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI)

From TipRanks Apr 17, 2024

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Johnson & Johnson (JNJ – Research Report) and Intr...

Johnson & Johnson (JNJ)

How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?

3 Long-Term Stocks to Buy on the Dip: April 2024

7 Blue-Chip Stocks to Buy on the Dip: April 2024

Spring Awakening: 3 Dow Stocks Emerging from Hibernation

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Johnson & Johnson (JNJ)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

JNJ Stock Predictions, Articles, and Johnson & Johnson News

Subscriber Sign in